North America Corneal Transplant Market Analysis

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

North America Corneal Transplant Market Analysis

  • Pharmaceutical
  • Published Report
  • Sep 2024
  • North America
  • 350 Pages
  • No of Tables: 102
  • No of Figures: 54

The North America corneal implants market is driven by several factors, including the increasing prevalence of corneal diseases, a growing aging population, advances in technology, increasing demand for minimally invasive procedures, rising awareness of corneal transplantation, government initiatives and funding, increasing adoption of hybrid and toric lenses, growing popularity of cross-linking procedures, expanding indications for corneal implants, and a competitive landscape that fosters innovation. These factors are collectively driving the demand for corneal implants, particularly in developed countries, as patients seek effective treatments for vision disorders and conditions such as keratoconus, Fuchs' dystrophy, and pseudophakic bullous keratopathy.

Data Bridge Market Research analyzes that the North America corneal transplant market is expected to reach USD  335.35 million by 2031 from USD 207.02 million in 2023, is growing with a CAGR of 6.2% in the forecast period of 2024 to 2031.

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE NORTH AMERICA CORNEAL IMPLANTS MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET END USER COVERAGE GRID

2.8 DBMR MARKET POSITION GRID

2.9 VENDOR SHARE ANALYSIS

2.1 SECONDARY SOURCES

2.11 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTLE ANALYSIS

4.2 PORTERS FIVE FORCES ANALYSIS

5 NORTH AMERICA CORNEAL TRANSPLANT MARKET: REGULATIONS

5.1 REGULATORY AUTHORITIES IN THE ASIA-PACIFIC REGION

5.2 NORTH AMERICA REGULATORY SCENARIO

5.3 EUROPE REGULATORY SCENARIO

5.4 MIDDLE EAST AND AFRICA REGULATORY SCENARIO

5.5 SOUTH AMERICA REGULATORY SCENARIO

6 CUSTOMIZATION

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 INCREASING PREVALENCE OF EYE DISEASES

7.1.2 RISING GERIATRIC POPULATION

7.1.3 TECHNOLOGICAL ADVANCEMENTS IN CORNEAL IMPLANTS

7.1.4 RISE IN MINIMALLY INVASIVE SURGERY IN CORNEAL TRANSPLANT

7.2 RESTRAINTS

7.2.1 HIGH COST ASSOCIATED WITH CORNEAL TRANSPLANT SURGERY

7.2.2 SHORTAGE OF DONORS IN CORNEAL TRANSPLANT

7.3 OPPORTUNITIES

7.3.1 RISE IN HEALTHCARE INFRASTRUCTURE

7.3.2 INCREASE IN PUBLIC AWARENESS AND EDUCATION

7.3.3 PARTNERSHIPS AND COLLABORATIONS ASSOCIATED WITH CORNEAL TRANSPLANTS

7.4 CHALLENGES

7.4.1 SURGICAL AND POST-SURGICAL COMPLICATIONS

7.4.2 LIMITED AWARENESS AND TRAINING

8 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY TYPE

8.1 OVERVIEW

8.2 HUMAN CORNEA

8.3 SYNTHETIC

9 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE

9.1 OVERVIEW

9.2 ENDOTHELIAL KERATOPLASTY

9.2.1 DESCEMET'S MEMBRANE ENDOTHELIAL KERATOPLASTY (DMEK)

9.2.2 DESCEMET'S STRIPPING ENDOTHELIAL KERATOPLASTY(DSEK)/DESCEMET'S STRIPPING AUTOMATED ENDOTHELIAL KERATOPLASTY (DSAEK)

9.3 PENETRATING KERATOPLASTY

9.4 ANTERIOR LAMELLAR KERATOPLASTY (ALK)

9.4.1 DEEP ANTERIOR LAMELLAR KERATOPLASTY (DALK)

9.4.2 SUPERFICIAL ANTERIOR LAMELLAR KERATOPLASTY (SALK)

9.5 CORNEAL LIMBAL STEM CELL TRANSPLANT

9.6 ARTIFICIAL CORNEA TRANSPLANT

9.7 OTHERS

10 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE

10.1 OVERVIEW

10.2 ALLOGRAFT

10.3 AUTOGRAFT

11 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY INDICATION

11.1 OVERVIEW

11.2 FUCH'S ENDOTHELIAL DYSTROPHY

11.3 INFECTIOUS KERATITIS

11.4 BULLOUS KERATOPATHY

11.5 KERATOCONUS

11.6 REGRAFT PROCEDURES

11.7 CORNEAL SCARRING

11.8 CORNEAL ULCERS

11.9 OTHERS

12 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE

12.1 OVERVIEW

12.2 PARTIAL THICKNESS GRAFTS (LAMELLAR)

12.2.1 DEEP LAMELLAR GRAFTS

12.2.2 SUPERFICIAL LAMELLAR GRAFTS

12.3 FULL THICKNESS GRAFTS (PENETRATING)

13 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE

13.1 OVERVIEW

13.2 CONVENTIONAL SURGERY

13.3 LASER-ASSISTED SURGERY

14 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY GENDER

14.1 OVERVIEW

14.2 FEMALE

14.3 MALE

15 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY AGE GROUP

15.1 OVERVIEW

15.2 GERIATRIC

15.3 ADULT

15.4 PEDIATRIC

16 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY END USER

16.1 OVERVIEW

16.2 HOSPITALS

16.3 EYE CLINICS

16.4 AMBULATORY SURGICAL CENTERS

16.5 ACADEMIC & RESEARCH INSTITUTES

16.6 OTHERS

17 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY REGION

17.1 NORTH AMERICA

17.1.1 U.S

17.1.2 CANADA

17.1.3 MEXICO

18 NORTH AMERICA CORNEAL TRANSPLANT MARKET: COMPANY LANDSCAPE

18.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

19 SWOT ANALYSIS

20 COMPANY PROFILES

20.1 ZEISS GROUP (CARL ZEISS MEDITEC AG.)

20.1.1 COMPANY SNAPSHOT

20.1.2 REVENUE ANALYSIS

20.1.3 COMPANY SHARE ANALYSIS

20.1.4 PRODUCT PORTFOLIO

20.1.5 RECENT DEVELOPMENTS

20.2 ALCON

20.2.1 COMPANY SNAPSHOT

20.2.2 REVENUE ANALYSIS

20.2.3 COMPANY SHARE ANALYSIS

20.2.4 PRODUCT PORTFOLIO

20.2.5 RECENT DEVELOPMENT

20.3 CORNEAGEN

20.3.1 COMPANY SNAPSHOT

20.3.2 COMPANY SHARE ANALYSIS

20.3.3 PRODUCT PORTFOLIO

20.3.4 RECENT DEVELOPMENT

20.4 ZIEMER OPHTHALMIC SYSTEMS AG

20.4.1 COMPANY SNAPSHOT

20.4.2 COMPANY SHARE ANALYSIS

20.4.3 PRODUCT PORTFOLIO

20.4.4 RECENT DEVELOPMENT

20.5 RUMEX INTERNATIONAL CO.

20.5.1 COMPANY SNAPSHOT

20.5.2 COMPANY SHARE ANALYSIS

20.5.3 PRODUCT PORTFOLIO

20.5.4 RECENT DEVELOPMENT

20.6 AJL OPHTHALMIC S.A.

20.6.1 COMPANY SNAPSHOT

20.6.2 PRODUCT PORTFOLIO

20.6.3 RECENT DEVELOPMENT

20.7 CORNEAT VISION

20.7.1 COMPANY SNAPSHOT

20.7.2 PRODUCT PORTFOLIO

20.7.3 RECENT DEVELOPMENT

20.8 FLORIDA LIONS EYE BANK

20.8.1 COMPANY SNAPSHOT

20.8.2 PRODUCT PORTFOLIO

20.8.3 RECENT DEVELOPMENT

20.9 KERAMED, INC.

20.9.1 COMPANY SNAPSHOT

20.9.2 PRODUCT PORTFOLIO

20.9.3 RECENT DEVELOPMENT

20.1 MASSACHUSETTS EYE AND EAR

20.10.1 COMPANY SNAPSHOT

20.10.2 PRODUCT PORTFOLIO

20.10.3 RECENT DEVELOPMENT

20.11 OCL VISION

20.11.1 COMPANY SNAPSHOT

20.11.2 SERVICE PORTFOLIO

20.11.3 RECENT DEVELOPMENT

20.12 OVATION INTERNATIONAL

20.12.1 COMPANY SNAPSHOT

20.12.2 PRODUCT PORTFOLIO

20.12.3 RECENT DEVELOPMENT

20.13 SAN DIEGO EYE BANK

20.13.1 COMPANY SNAPSHOT

20.13.2 SERVICE PORTFOLIO

20.13.3 RECENT DEVELOPMENT

21 QUESTIONNAIRE

22 RELATED REPORTS

List of Table

TABLE 1 NUMBER OF CORNEAL TRANSPLANTS IN EACH COUNTRY, BY SURGERY TYPE

TABLE 2 NUMBER OF CORNEAL TRANSPLANTS IN EACH COUNTRY, BY INDICATION

TABLE 3 NUMBER OF CORNEAL TRANSPLANTS IN EACH COUNTRY, BY AGE

TABLE 4 NUMBER OF PATIENTS WAITING IN EACH COUNTRY

TABLE 5 NUMBER OF CORNEAL TRANSPLANTS IN EACH COUNTRY, BY DONOR TYPE

TABLE 6 PERCENTAGE OF HOSPITALS IN EACH COUNTRY WHERE CORNEAL TRANSPLANTS ARE PERFORMED (CLINICS OR HOSPITALS).

TABLE 7 AVERAGE COST FOR THE CORNEAL TRANSPLANT (PER/EYE) WITH RESPECT TO THE PROCEDURE TYPE IN ASIA-PACIFIC (INDIA)

TABLE 8 AVERAGE COST FOR THE CORNEAL TRANSPLANT WITH RESPECT TO THE PROCEDURE TYPE IN EUROPE

TABLE 9 AVERAGE COST FOR THE CORNEAL TRANSPLANT WITH RESPECT TO THE PROCEDURE TYPE IN SOUTH AMERICA

TABLE 10 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 11 NORTH AMERICA HUMAN CORNEA IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 12 NORTH AMERICA SYNTHETIC IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 13 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)

TABLE 14 NORTH AMERICA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 15 NORTH AMERICA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 16 NORTH AMERICA PENETRATING KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 17 NORTH AMERICA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 18 NORTH AMERICA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 19 NORTH AMERICA CORNEAL LIMBAL STEM CELL TRANSPLANT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 20 NORTH AMERICA ARTIFICIAL CORNEA TRANSPLANT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 21 NORTH AMERICA OTHERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 22 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)

TABLE 23 NORTH AMERICA ALLOGRAFT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 24 NORTH AMERICA ALLOGRAFT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 25 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)

TABLE 26 NORTH AMERICA FUCH'S ENDOTHELIAL DYSTROPHY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 27 NORTH AMERICA INFECTIOUS KERATITIS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 28 NORTH AMERICA BULLOUS KERATOPATHY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 29 NORTH AMERICA KERATOCONUS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 30 NORTH AMERICA REGRAFT PROCEDURES IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 31 NORTH AMERICA CORNEAL SCARRING IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 32 NORTH AMERICA CORNEAL ULCERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 33 NORTH AMERICA OTHERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 34 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)

TABLE 35 NORTH AMERICA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 36 NORTH AMERICA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)

TABLE 37 NORTH AMERICA FULL THICKNESS GRAFTS (PENETRATING) IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 38 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)

TABLE 39 NORTH AMERICA CONVENTIONAL SURGERY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 40 NORTH AMERICA LASER-ASSISTED SURGERY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 41 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 42 NORTH AMERICA FEMALE IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 43 NORTH AMERICA MALE IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 44 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)

TABLE 45 NORTH AMERICA GERIATRIC IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 46 NORTH AMERICA ADULT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 47 NORTH AMERICA PEDIATRIC IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 48 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 49 NORTH AMERICA HOSPITALS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 50 NORTH AMERICA EYE CLINICS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 51 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 52 NORTH AMERICA ACADEMIC & RESEARCH INSTITUTES IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 53 NORTH AMERICA OTHERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 54 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 55 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)

TABLE 56 NORTH AMERICA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 57 NORTH AMERICA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 58 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 59 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)

TABLE 60 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)

TABLE 61 NORTH AMERICA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)

TABLE 62 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)

TABLE 63 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)

TABLE 64 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 65 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)

TABLE 66 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 67 U.S. CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)

TABLE 68 U.S. ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 69 U.S. ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 70 U.S. CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 71 U.S. CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)

TABLE 72 U.S. CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)

TABLE 73 U.S. PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)

TABLE 74 U.S. CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)

TABLE 75 U.S. CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)

TABLE 76 U.S. CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 77 U.S. CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)

TABLE 78 U.S. CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 79 CANADA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)

TABLE 80 CANADA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 81 CANADA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 82 CANADA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 83 CANADA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)

TABLE 84 CANADA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)

TABLE 85 CANADA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)

TABLE 86 CANADA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)

TABLE 87 CANADA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)

TABLE 88 CANADA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 89 CANADA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)

TABLE 90 CANADA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 91 MEXICO CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)

TABLE 92 MEXICO ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 93 MEXICO ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 94 MEXICO CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 95 MEXICO CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)

TABLE 96 MEXICO CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)

TABLE 97 MEXICO PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)

TABLE 98 MEXICO CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)

TABLE 99 MEXICO CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)

TABLE 100 MEXICO CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 101 MEXICO CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)

TABLE 102 MEXICO CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)

List of Figure

FIGURE 1 NORTH AMERICA CORNEAL TRANSPLANT MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA CORNEAL TRANSPLANT MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA CORNEAL TRANSPLANT MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA CORNEAL TRANSPLANT MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA CORNEAL TRANSPLANT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA CORNEAL TRANSPLANT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA CORNEAL TRANSPLANT MARKET: MARKET END USER COVERAGE GRID

FIGURE 8 NORTH AMERICA CORNEAL TRANSPLANT MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA CORNEAL TRANSPLANT MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 NORTH AMERICA CORNEAL TRANSPLANT MARKET: SEGMENTATION

FIGURE 11 SIX SEGMENTS COMPRISE THE NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE

FIGURE 12 EXECUTIVE SUMMARY

FIGURE 13 STRATEGIC DECISIONS

FIGURE 14 INCREASING PREVALENCE OF EYE DISEASES IS DRIVING THE GROWTH OF THE NORTH AMERICA CORNEAL TRANSPLANT MARKET FROM 2024 TO 2031

FIGURE 15 THE ENDOTHELIAL KERATOPLASTY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA CORNEAL TRANSPLANT MARKET IN 2024 AND 2031

FIGURE 16 DROC ANALYSIS

FIGURE 17 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY TYPE, 2023

FIGURE 18 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY TYPE, 2024-2031 (USD THOUSAND)

FIGURE 19 NORTH AMERICA CORNEAL TRANSPLANT MARKET: TYPE, CAGR (2024-2031)

FIGURE 20 NORTH AMERICA CORNEAL TRANSPLANT MARKET: TYPE, LIFELINE CURVE

FIGURE 21 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY PROCEDURE TYPE, 2023

FIGURE 22 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY PROCEDURE TYPE, 2024-2031 (USD THOUSAND)

FIGURE 23 NORTH AMERICA CORNEAL TRANSPLANT MARKET: PROCEDURE TYPE, CAGR (2024-2031)

FIGURE 24 NORTH AMERICA CORNEAL TRANSPLANT MARKET: PROCEDURE TYPE, LIFELINE CURVE

FIGURE 25 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY DONOR TYPE, 2023

FIGURE 26 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY DONOR TYPE, 2024-2031 (USD THOUSAND)

FIGURE 27 NORTH AMERICA CORNEAL TRANSPLANT MARKET: DONOR TYPE, CAGR (2024-2031)

FIGURE 28 NORTH AMERICA CORNEAL TRANSPLANT MARKET: DONOR TYPE, LIFELINE CURVE

FIGURE 29 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY INDICATION, 2023

FIGURE 30 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY INDICATION, 2024-2031 (USD THOUSAND)

FIGURE 31 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY INDICATION, CAGR (2024-2031)

FIGURE 32 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY INDICATION, LIFELINE CURVE

FIGURE 33 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY GRAFT TYPE, 2023

FIGURE 34 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY GRAFT TYPE, 2024-2031 (USD THOUSAND)

FIGURE 35 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY GRAFT TYPE, CAGR (2024-2031)

FIGURE 36 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY GRAFT TYPE, LIFELINE CURVE

FIGURE 37 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY SURGERY TYPE, 2023

FIGURE 38 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY SURGERY TYPE, 2024-2031 (USD THOUSAND)

FIGURE 39 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY SURGERY TYPE, CAGR (2024-2031)

FIGURE 40 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY SURGERY TYPE, LIFELINE CURVE

FIGURE 41 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY GENDER, 2023

FIGURE 42 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY GENDER, 2024-2031 (USD THOUSAND)

FIGURE 43 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY GENDER, CAGR (2024-2031)

FIGURE 44 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY GENDER, LIFELINE CURVE

FIGURE 45 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY AGE GROUP, 2023

FIGURE 46 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY AGE GROUP, 2024-2031 (USD THOUSAND)

FIGURE 47 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY AGE GROUP, CAGR (2024-2031)

FIGURE 48 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY AGE GROUP, LIFELINE CURVE

FIGURE 49 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY END USER, 2023

FIGURE 50 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY END USER, 2024-2031 (USD THOUSAND)

FIGURE 51 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY END USER, CAGR (2024-2031)

FIGURE 52 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY END USER, LIFELINE CURVE

FIGURE 53 NORTH AMERICA CORNEAL TRANSPLANT MARKET: SNAPSHOT (2023)

FIGURE 54 NORTH AMERICA CORNEAL TRANSPLANT MARKET: COMPANY SHARE 2023 (%)

Frequently Asked Questions

The market is segmented based on , By Procedure Type (Endothelial Keratoplasty, Penetrating Keratoplasty, Anterior Lamellar Keratoplasty (ALK), Corneal Limbal Stem Cell Transplant, Artifical Cornea Transplant, and Others), Type (Human Cornea and Synthetic), Donor Type (Autograft and Allograft), Graft Type (Partial Thickness Grafts (Lamellar) and Full Thickness Grafts (Penetrating)), Surgery Type (Conventional Surgery, Laser-Assisted Surgery), Indication (Fuch's Endothelial Dystrophy, Infectious Keratitis, Bullous Keratopathy, Keratoconus, Regraft Procedures, Corneal Scarring, Corneal Ulcers, and Others), Gender (Female and Male), Age Group (Geriatric, Adult, and Pediatric), End User (Hospitals, Eye Clinics, Ambulatory Surgical Centers, Academic & Research Institutes, and Others) - Industry Trends and Forecast to 2031 .
The North America Corneal Transplant Market size was valued at USD 207.02 USD Million in 2023.
The North America Corneal Transplant Market is projected to grow at a CAGR of 6.2% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada, Mexico.